SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-96-001614
Filing Date
1996-08-14
Accepted
1996-08-14 00:00:00
Documents
9
Period of Report
1996-06-30
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR GUILFORD PHARMACEUTICALS, INC. 10-Q 58192
2 MARKETING, SALES & DISTRIBUTION RIGHTS AGREEMENT EX-10.40 132295
3 MANUFACTURING & SUPPLY AGREEMENT EX-10.41 79629
4 STOCK PURCHASE AGREEMENT EX-10.42 42479
5 LOAN AGREEMENT EX-10.43 108877
6 1993 EMPLOYEE SHARE OPTION PLAN EX-10.44 497
7 AMENDMENT TO THE DIRECTORS' STOCK OPTION PLAN EX-10.45 756
8 COMPUTATION OF PER SHARE EARNINGS EX-11.1 2608
9 FINANCIAL DATA SCHEDULE EX-27.2 2313
  Complete submission text file 0000950133-96-001614.txt   429881
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21221 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23736 | Film No.: 96613914
SIC: 2834 Pharmaceutical Preparations